Related Experiment Videos
Staphylococcus aureus resistance on titanium coated with multivalent PEGylated-peptides
Xiaojuan Khoo1, George A O'Toole, Shrikumar A Nair
1Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA.
Biomaterials
|September 25, 2010
Summary
Multivalent titanium-binding peptides (TBPs) create robust, bacteriophobic coatings for medical implants. The tetravalent TBP(4)-PEG coating effectively prevents Staphylococcus aureus adhesion and biofilm formation, enhancing implant safety and longevity.
Area of Science:
- Biomaterials Science
- Surface Chemistry
- Infectious Disease
Background:
- Bacterial infections are a major cause of orthopedic implant failure.
- Previous work demonstrated PEGylated titanium-binding peptides (TBPs) create bacteriophobic surfaces resisting protein adsorption and Staphylococcus aureus (S. aureus) adhesion.
Purpose of the Study:
- To investigate the impact of multiple TBP repeats on the performance of bacteriophobic surface coatings.
- To evaluate the efficacy of mono-, di-, and tetravalent PEGylated TBPs against S. aureus colonization in vitro.
Main Methods:
- Synthesis and characterization of mono-, di-, and tetravalent PEGylated TBPs.
- Assessment of peptide binding affinity and serum stability.
- In vitro evaluation of S. aureus attachment and biofilm formation on coated titanium surfaces.
Main Results:
- Coating performance improved with an increasing number of TBP repeats.
- The tetravalent TBP(4)-PEG coating exhibited superior performance in all tested assays.
- TBP(4)-PEG demonstrated significant serum resistance and effectively prevented S. aureus colonization and biofilm development.
Conclusions:
- Multivalency significantly enhances the stability and efficacy of TBP-based surface coatings.
- The tetravalent TBP(4)-PEG coating shows great promise for developing improved anti-infective surfaces for medical implants.
- These findings support the clinical potential of multivalency-driven surface engineering for enhanced in vivo performance.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Defense Against Bacterial Pathogens
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...